Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer's Disease
Effect Increase
Trial Design Randomized trial
Trial Length 2-4 Weeks
Number of Subjects 8
Sex Both Genders
Age Range 65+
Notes for this study:
3 weeks supplementation of phosphatidylserine (source not stated, likely bovine cortex based) was able to increase global glucose utilization by 14.8% in the brains of persons with Alzheimer's relative to baseline; this was thought to underlie the benefits observed on symptoms of cognitive decline.